Literature DB >> 9406869

Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains.

Y Kitamura1, S Shimohama, T Ota, Y Matsuoka, Y Nomura, T Taniguchi.   

Abstract

Recent studies suggest that inflammatory activation occurs in the brains of patients with Alzheimer's disease (AD). Several transcription factors such as nuclear factor-kappaB (NF-kappaB) and signal transducer and activator of transcription-1 (STAT1) may be activated in glial cells by a number of cytokines and then translocated from the cytosol to the nucleus. We assessed NF-kappaB and STAT1 in temporal cortex from normal and AD brains using specific antibodies. NF-kappaB p65 in the particulate fraction and STAT1alpha in both the particulate and cytosolic fractions were more abundant in AD cases than in controls. These findings suggest that the increased NF-kappaB and STAT1alpha in cell nuclei may be involved in inflammatory activation in AD brains.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406869     DOI: 10.1016/s0304-3940(97)00797-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Neuroinflammatory and Amyloidogenic Activities of IL-32β in Alzheimer's Disease.

Authors:  Hyung-Mun Yun; Jin A Kim; Chul Ju Hwang; Peng Jin; Myung Ki Baek; Jin Moo Lee; Ji Eun Hong; Sang Min Lee; Sang Bae Han; Ki Wan Oh; Dong Young Choi; Do Young Yoon; Jin Tae Hong
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

Review 3.  Methylmercury: recent advances in the understanding of its neurotoxicity.

Authors:  Michael Aschner; Tore Syversen
Journal:  Ther Drug Monit       Date:  2005-06       Impact factor: 3.681

4.  S100beta induction of the proinflammatory cytokine interleukin-6 in neurons.

Authors:  Y Li; S W Barger; L Liu; R E Mrak; W S Griffin
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

Review 5.  Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments.

Authors:  Xiao Liu; Kaiyue Wang; Xing Wei; Tian Xie; Bin Lv; Qian Zhou; Xiaoying Wang
Journal:  Neurochem Res       Date:  2021-02-01       Impact factor: 3.996

6.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

7.  Management of oxidative stress in the CNS: the many roles of glutathione.

Authors:  B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

8.  Protective effect of epigallocatechin-3-gallate on ischemia/reperfusion-induced injuries in the heart: STAT1 silencing flavonoid.

Authors:  Elena Darra; Kazuo Shoji; Sofia Mariotto; Hisanori Suzuki
Journal:  Genes Nutr       Date:  2007-10-11       Impact factor: 5.523

9.  Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in β-amyloid rat model of Alzheimer's disease.

Authors:  Aiguo Xuan; Dahong Long; Jianhua Li; Weidong Ji; Meng Zhang; Lepeng Hong; Jihong Liu
Journal:  J Neuroinflammation       Date:  2012-08-17       Impact factor: 8.322

10.  Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer's disease mice model.

Authors:  Peng Jin; Jin-A Kim; Dong-Young Choi; Young-Jung Lee; Heon Sang Jung; Jin Tae Hong
Journal:  J Neuroinflammation       Date:  2013-01-05       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.